Balis, 2002, J Natl Cancer Inst, 94, 78, 10.1093/jnci/94.2.78
Dunstan, 2002, J Natl Cancer Inst, 94, 88, 10.1093/jnci/94.2.88
Vassilev, 2001, Anticancer Drug Des, 16, 7
Frankfurt, 2003, Chem-Biol Interact, 145, 89, 10.1016/S0009-2797(02)00241-7
Johnson, 2001, Br J Cancer, 84, 1424, 10.1054/bjoc.2001.1796
Trielli, 1996, J Cell Biol, 135, 689, 10.1083/jcb.135.3.689
Lu, 2000, Cancer Res, 60, 6465
Quto, 2002, Cancer Chemother Pharmacol, 49, 167, 10.1007/s00280-001-0403-5
Howells, 2002, Mol Cancer Ther, 1, 1161
Woynarowska, 2002, Biochim Biophys Acta, 1587, 309, 10.1016/S0925-4439(02)00094-7
Blajeski, 2001, Exp Cell Res, 270, 277, 10.1006/excr.2001.5349
Frankfurt, 1996, Exp Cell Res, 226, 387, 10.1006/excr.1996.0240
Frankfurt, 2001, J Histochem Cytochem, 49, 369, 10.1177/002215540104900311
Frankfurt, 2001, J Immunol Methods, 253, 133, 10.1016/S0022-1759(01)00387-8
Zamzani, 1999, Nature, 401, 127, 10.1038/43591
Monks, 1991, J Natl Cancer Inst, 83, 757, 10.1093/jnci/83.11.757
Carmichael, 1987, Cancer Res, 47, 936
Sheers, 2001, Toxicol In Vitro, 15, 153, 10.1016/S0887-2333(00)00062-X
Evans, 2001, Toxicol In Vitro, 15, 579, 10.1016/S0887-2333(01)00064-9
Senderowicz, 2000, J Natl Cancer Inst, 92, 376, 10.1093/jnci/92.5.376
Koornstra, 2003, Crit Rev Oncol Hematol, 45, 37, 10.1016/S1040-8428(01)00228-1
Frankfurt, 1997, Clinical Cancer Res, 3, 465
Pestell, 2000, Mol Pharmacol, 57, 503, 10.1124/mol.57.3.503
Mathiasen, 2002, Trends Mol Med, 8, 212, 10.1016/S1471-4914(02)02328-6
Alonso, 2003, Mol Cancer Ther, 2, 139, 10.4161/cbt.214
